| ACS | acute coronary syndrome |
| ADH | antidiuretic hormone |
| ADM | adrenomedullin |
| AMI | acute myocardial infarction |
| ANP | atrial natriuretic peptide |
| AVP | arginine vasopressin |
| BNP | B-type natriuretic peptide |
| BSA | bovine serum albumin |
| CHD | coronary heart disease |
| CHF | congestive heart failure |
| CK | creatine phosphokinase |
| CRP | C-reactive protein |
| cTnI | cardiac troponin I |
| cTnT | cardiac troponin T |
| CV | cyclic voltammetry |
| CVDs | cardiovascular diseases |
| DNA | deoxyribonucleic acid |
| DPV | differential pulse voltammetric |
| EIS | electrochemical impedance spectroscopy |
| ELISA | enzyme-linked immunosorbent assay |
| ELONA | enzyme-linked oligonucleotide assay |
| FET | field-effect transistor |
| FICA | fluorescence immunochromatographic assay |
| GDF15 | growth differentiation factor 15 |
| GDF8 | growth differentiation factor 8, myostatin |
| HF | heart failure |
| hFABP | heart-type fatty acid-binding protein |
| HSA | human serum albumin |
| IgE | immunoglobulin E |
| IL-6 | interleukin-6 |
| LOD | limit of detection |
| MR-proADM | mid-region-proADM |
| Nt | nucleotides |
| NT-proBNP | N-terminal proBNP |
| POC | point-of-care |
| RNA | ribonucleic acid |
| SELEX | systematic evolution of ligands by exponential enrichment |
| SERS | surface-enhanced Raman spectroscopy |
| SOMAmer | slow off-rate modified aptamers |
| SPR | surface plasmon resonance |
| sST2 | soluble suppression of tumorigenicity 2 |
| ST2 | suppression of tumorigenicity 2 |
| ST2L | transmembrane suppression of tumorigenicity 2 |
| SWV | square wave voltammetry |
| TGF-β | transforming growth factor-β |
| TNFα | tumor necrosis factor alpha |
| WHO | world health organization |